Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
13,455,447
-
Share change
-
+13,455,447
-
Total reported value
-
$201,636,000
-
Price per share
-
$15.01
-
Number of holders
-
29
-
Value change
-
+$201,635,944
-
Number of buys
-
29
Institutional Holders of SATSUMA PHARMACEUTICALS INC - COM (STSA) as of Q3 2019
As of 30 Sep 2019,
SATSUMA PHARMACEUTICALS INC - COM (STSA) was held by
29 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,455,447 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., WELLINGTON MANAGEMENT GROUP LLP, TPG Group Holdings (SBS) Advisors, Inc., CITADEL ADVISORS LLC, CAXTON CORP, Cormorant Asset Management, LP, ADAGE CAPITAL PARTNERS GP, L.L.C., EVENTIDE ASSET MANAGEMENT, LLC, CREDIT SUISSE AG/, and Zimmer Partners, LP.
This page lists
29
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.